Alvelestat (MPH966)

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Alpha-1 Antitrypsin Deficiency (AATD)

Drug Information

Target Indication

Alpha-1 Antitrypsin Deficiency (AATD)

Clinical Trial

Last updated: 10/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

MREO

Mereo BioPharma Group plc

Related Pipeline

Osteogenesis Imperfecta

Alpha 1-Antitrypsin Deficiency

Solid Tumor, Adult

Hypogonadotropic Hypogonadism

Endometriosis

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts